Akari Therapeutics Stories Second Quarter 2021 Monetary Outcomes and Highlights Current Medical Progress September 23, 2021 admin Financial E-learning Presently opening websites for Part III research of nomacopan in bullous pemphigoid (BP). Part III research of nomacopan in extreme pediatric hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA) open... Continue Reading
